Human Reproduction, Vol. 10, No. 12, pp. 3091-3096, 1995
© 1995 European Society of Human Reproduction and Embryology
research-article |
Oocyte and embryo quality as well as pregnancy rate in intracytoplasmic sperm injection are not affected by high follicular phase serum progesterone
Centre for Reproductive Medicine, Dutch-speaking Brussels Free University Laarbeeklaan 101, 1090 Brussels, Belgium
Correspondence: 1To whom correspondence should be addressed
The effect of elevated serum progesterone concentrations (>1 ng/1) on or before the day of human chorionic gonadotrophin (HCG) injection on the outcome of women receiving gonadotrophin-releasing hormone analogue (GnRHa)/ human menopausal gonadotrophin (HMG) for ovarian stimulation prior to intracytoplasmic sperm injection (ICSI) was evaluated. A total of 1275 ICSI cycles were analysed retrospectively. In 53 cycles (4.5%), serum progesterone concentrations were > 1 ng/ml. Patients in the high progesterone group had significantly higher oestradiol and luteinizing hormone concentrations on the day of HCG injection. The characteristics of the cumulus-corona cell complexes and the nuclear maturity of the oocytes were similar in the groups of patients with high and low serum progesterone levels. Fertilization and cleavage rates as well as embryo quality were not different in the two groups. No difference in implantation or clinical pregnancy rates was observed between the high progesterone and low progesterone groups. Moreover, the cumulative exposure to progesterone during the follicular phase, as expressed by the area under the curve (AUC), and the duration of exposure to high serum progesterone levels (>1 ng/ml) were not significantly different between pregnant and non-pregnant women in the high progesterone group. We conclude that in ICSI cycles pretreated with GnRHa, increased serum progesterone concentrations on or before the day of HCG injection do not affect ICSI outcome.
Key words: follicular phase/GnRHa/HMG/ovarian stimulation/intracytoplasmic/sperm injection/serum progesterone
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
D. Kyrou, B. Popovic-Todorovic, H.M. Fatemi, C. Bourgain, P. Haentjens, L. Van Landuyt, and P. Devroey Does the estradiol level on the day of human chorionic gonadotrophin administration have an impact on pregnancy rates in patients treated with rec-FSH/GnRH antagonist? Hum. Reprod., November 1, 2009; 24(11): 2902 - 2909. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.A. Venetis, E.M. Kolibianakis, E. Papanikolaou, J. Bontis, P. Devroey, and B.C. Tarlatzis Is progesterone elevation on the day of human chorionic gonadotrophin administration associated with the probability of pregnancy in in vitro fertilization? A systematic review and meta-analysis Hum. Reprod. Update, July 1, 2007; 13(4): 343 - 355. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.A.B. Melo, M. Meseguer, N. Garrido, E. Bosch, A. Pellicer, and J. Remohi The significance of premature luteinization in an oocyte-donation programme Hum. Reprod., June 1, 2006; 21(6): 1503 - 1507. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Nawroth and M. Ludwig What is the 'ideal' duration of progesterone supplementation before the transfer of cryopreserved-thawed embryos in estrogen/progesterone replacement protocols? Hum. Reprod., May 1, 2005; 20(5): 1127 - 1134. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Humaidan, H. Ejdrup Bredkjaer, L. Bungum, M. Bungum, M.L. Grondahl, L. Westergaard, and C. Yding Andersen GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study Hum. Reprod., May 1, 2005; 20(5): 1213 - 1220. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. De Rycke, I. Georgiou, K. Sermon, W. Lissens, P. Henderix, H. Joris, P. Platteau, A. Van Steirteghem, and I. Liebaers PGD for autosomal dominant polycystic kidney disease type 1 Mol. Hum. Reprod., January 1, 2005; 11(1): 65 - 71. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. De Vos, H. Van de Velde, H. Joris, and A. Van Steirteghem In-vitro matured metaphase-I oocytes have a lower fertilization rate but similar embryo quality as mature metaphase-II oocytes after intracytoplasmic sperm injection Hum. Reprod., July 1, 1999; 14(7): 1859 - 1863. [Abstract] [Full Text] [PDF] |
||||


